Association of p62/SQSTM1 excess and oral carcinogenesis.

Association of p62/SQSTM1 excess and oral carcinogenesis.
复制标题

DOI:
10.1371/journal.pone.0074398
复制
发表时间:
2013
期刊:
影响因子:
3.7
通讯作者:
Okabe H
Okabe H
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Inui T;Chano T;Takikita-Suzuki M;Nishikawa M;Yamamoto G;Okabe H

文献摘要

参考文献

被引文献

相似文献

p62/SQSTM1(自噬相关蛋白1)从未在口腔上皮中进行过评估。为了阐明p62/SQSTM1在口腔上皮癌变中的作用,对54例癌组织和14例低级别上皮内瘤变进行了p62/SQSTM1和Nrf2的免疫组化评估。还在口腔癌细胞中设计了p62/SQSTM1基因敲低实验,并分析了Nrf2通路、谷胱甘肽(GSH)含量和活性氧(ROS)积累。在一个口腔癌临床队列中探讨了p62/SQSTM1过量与预后的关系。p62/SQSTM1过量在癌组织中更为明显,但Nrf2在几乎所有口腔上皮样本中都很丰富。在口腔癌细胞中,p62/SQSTM1基因敲低不影响Nrf2 - Keap1通路,但显著降低了GSH含量,随后导致ROS积累,并在照射条件下抑制细胞生长。最后,在一个临床队列中,p62/SQSTM1过量与不良预后相关。在口腔上皮癌变过程中,p62/SQSTM1过量在诱导GSH方面起作用,而非在Nrf2积累方面,并且可能导致对细胞毒性应激(如放疗或化疗)产生抗性。p62/SQSTM1的免疫组化评估可能是识别口腔鳞状细胞癌早期癌变、放化疗抗性或不良预后的一个潜在重要标志物。
p62/SQSTM1 (sequestosome1) has never been evaluated in oral epithelium. In order to clarify the role of p62/SQSTM1 in carcinogenesis in oral epithelium, both p62/SQSTM1 and Nrf2 were immunohistochemically evaluated in 54 carcinomas and 14 low grade dysplasias. p62/SQSTM1 knockdowns were also designed in oral cancer cells, and we analyzed the Nrf2 pathway, GSH contents and ROS accumulation. The association between p62/SQSTM1 excess and prognosis was addressed in a clinical cohort of oral carcinoma cases. p62/SQSTM1 excess was more obvious in carcinomas, but Nrf2 was abundant in almost all samples of the oral epithelium. In oral carcinoma cells, p62/SQSTM1 knockdown did not affect the Nrf2-Keap1 pathway but did significantly reduce GSH content with subsequent ROS accumulation, and caused cell growth inhibition in the irradiated condition. Finally, p62/SQSTM1 excess was associated with poor prognosis in a clinical cohort. In oral epithelial carcinogenesis, p62/SQSTM1 excess played a role in GSH induction rather than Nrf2 accumulation, and may cause resistance to cytotoxic stresses such as radiation or chemotherapy. Immunohistochemical evaluation of p62/SQSTM1 may be a potential significant marker to identify early carcinogenesis, chemo-radiotherapeutic resistance or poor prognosis of oral squamous cell carcinomas.
DOI: 10.1016/s0002-9440(10)61770-1
发表时间: 2001-09-01
影响因子: 6
作者:
Lu, ML;Nakamura, RM;Tan, EM
通讯作者: Tan, EM
DOI: 10.1101/gad.13.1.76
发表时间: 1999-01-01
影响因子: 10.5
作者:
Itoh, K;Wakabayashi, N;Yamamoto, M
通讯作者: Yamamoto, M
DOI: 10.1073/pnas.172398899
发表时间: 2002-09-03
影响因子: 11.1
作者:
Dinkova-Kostova, AT;Holtzclaw, WD;Talalay, P
通讯作者: Talalay, P
DOI: 10.1038/ncb2021
发表时间: 2010-03-01
影响因子: 21.3
作者:
Komatsu, Masaaki;Kurokawa, Hirofumi;Yamamoto, Masayuki
通讯作者: Yamamoto, Masayuki
DOI: 10.1016/j.bbrc.2011.07.101
发表时间: 2011-08-26
影响因子: 3.1
作者:
Bui, Chi-Bao;Shin, Jaekyoon
通讯作者: Shin, Jaekyoon